A carregar...
Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
BACKGROUND AND OBJECTIVE: Pirfenidone is an oral antifibrotic agent that is approved in several countries for the treatment of idiopathic pulmonary fibrosis (IPF). We performed a comprehensive analysis of safety across four clinical trials evaluating pirfenidone in patients with IPF. METHODS: All pa...
Na minha lista:
| Publicado no: | Respirology |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230393/ https://ncbi.nlm.nih.gov/pubmed/24836849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.12297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|